Table 3. Multivariate analysis for disease-free survival.
HR=hazard ratio; CI=confidence interval; HER2=human epidermal growth factor receptor 2; NAC=neoadjuvant chemotherapy; cN=clinical node; ypN=post-NAC pathologic node; LVI=lymphovascular invasion.
*HER2 enriched subgroup versus luminal B subgroup.